In breast cancer stem cells (BCSCs) the overexpression of the HAS2 is implicated in the new synthesis of hyaluronic acid, a major polysaccharide component of the ECM which drives the physical interaction to TAMs, via CD44 receptor expressed on their surface. The gene discussed is HAS2; the disease is breast carcinoma.